Keynote speakers

Dan I. Andersson

Dan I. Andersson

Department of Medical Biochemistry and Microbiology, University of Uppsala

The research of Prof. Andersson addresses the mechanisms and dynamics of evolution in bacteria and how various factors, such as the extent and type of genetic variation, strength of selection pressures, compensatory mutations and population dynamics, affect the tempo and mode of adaptive evolution. The research particularly focuses on genome variability and stability, and the mechanisms and dynamics of antibiotic resistance evolution.

For more, see here.

Florian altermatt

Florian Altermatt

Institute of Evolutionary Biology and Environmental Studies, University of Zurich, Switzerland

The research of Swiss National Science Foundation Prof. Altermatt seeks to understand how species occur in space and time, how they interact, and how processes such as species invasion, dispersal or climate change affect natural communities. Both experimental and a comparative approaches are employed, as well as integrated with theoretical models. Current interest especially lies in how asymmetric dispersal and invasion affect diversity and species interactions in riverine systems.

For more, see here.

Michael Brockhurst

Michael Brockhurst

Department of Biology, University of York

The research of Prof. Brockhurst is centered on the important consequences of rapid contemporary evolution, particularly in microbes whose short generation times and large population sizes result in high evolutionary rates. Current interests include examining the role of coevolution between species as a driver of adaptation and diversification, and as a force shaping the structure and function of microbial communities; integrating coevolution into our understanding of vector-mediated horizontal gene transfer (i.e., conjugation and transduction); understanding the consequences of within-host evolution for the prognosis and treatment of chronic bacterial infections with a focus on Pseudomonas aeruginosa lung infections; and analysing the evolutionary risks of novel antimicrobial therapies with a focus on antimicrobial peptides.

For more, see here.